Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

27 Apr 2006 17:09

Compagnie de Saint-Gobain27 April 2006 April 27, 2006 press release DISPOSAL OF SAINT-GOBAIN CALMAR Saint-Gobain has signed today an agreement regarding the sale of its subsidiarySaint-Gobain Calmar to MeadWestvaco Corporation. Calmar is a leading globalmanufacturer of plastic dispensing and spraying systems for cosmetics andfragrance, personal care as well as pharmaceutical industries. The transaction values Calmar at $745 million (of which $710 million in cashpaid by MeadWestvaco and $35 million of eliminated commitments by Saint-Gobain).In 2005, Calmar reported a pro-forma EBITDA of $72.7 million. Acquired by the Saint-Gobain Group in 1998, Calmar reported pro-forma sales of$403 million in 2005 and has approximately 2,700 employees based in 10production sites. Calmar will benefit from MeadWestvaco's financial capacity and global packagingstrategy, which should support its future development as a major player in itsbusiness. With annual revenues exceeding $6 billion, MeadWestvaco is a leading globalpackaging company that delivers high-value packaging solutions and products tocompanies in the food and beverage, media and entertainment, personal care,cosmetic and healthcare industries. MeadWestvaco employs approximately 23,000people around the world. The completion of the transaction, which is subject to the approval of therelevant anti-trust authorities, should be effective before the end of June2006. As it was communicated following the acquisition of BPB, the Saint-Gobain Groupis implementing a dynamic strategy of active portfolio management, consistentwith its business model. Investor Relations Department Mrs Florence TRIOU-TEIXEIRA Tel.: +33 1 47 62 45 19Mr Alexandre ETUY Tel.: +33 1 47 62 37 15 Fax.: +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 20207:12 amRNSCo-optation of a director
30th Mar 20207:07 amRNSIssue of Debt
23rd Mar 20207:34 amRNSCoronavirus pandemic update
10th Mar 20207:06 amRNSDisposal
28th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 20204:59 pmRNSFull-Year Results 2019
30th Jan 20207:02 amRNSAcquisition
24th Jan 20207:00 amRNSResolution of asbestos liabilities
21st Jan 20207:06 amRNSCDP Climate change A List
7th Jan 20205:07 pmRNSAcquisition
7th Jan 20207:07 amRNSAcquisition
6th Jan 20205:05 pmRNSDisposal
20th Dec 20197:08 amRNSDisposal
2nd Dec 20197:35 amRNSSaint-Gobain completes the divestment of DMTP
29th Nov 20195:15 pmRNSNew production line
29th Nov 20197:07 amRNSCancelation of shares
13th Nov 20197:00 amRNSAcquisition
4th Nov 20195:08 pmRNSDisposal
4th Nov 20197:04 amRNSDisposal
25th Oct 201912:18 pmRNS3rd Quarter Results
16th Oct 20197:07 amRNSAcquisition
7th Oct 20195:16 pmRNSDisposal
1st Oct 20195:07 pmRNSDisposal
30th Sep 20195:39 pmRNSDisposal
30th Sep 20197:21 amRNSDisposal
23rd Sep 20195:08 pmRNSCommitment
12th Sep 20196:15 pmRNSAmended Final Terms
26th Jul 20197:00 amRNSHalf-year Report
18th Jul 20195:16 pmRNSDisposal
1st Jul 20197:07 amRNSAccounting standards
19th Jun 20197:54 amRNSDisposal
14th Jun 20195:02 pmRNSCancellation of shares
7th Jun 20197:00 amRNSAGM Statement
28th May 20196:11 pmRNSAcquisition
20th May 20197:48 amRNSDisposal
14th May 20195:44 pmRNSFinal Terms
14th May 20195:16 pmRNSDisposal
2nd May 20195:32 pmRNSFinal Terms
25th Apr 20194:59 pmRNS1st Quarter Results
24th Apr 20197:08 amRNSAcquisition
8th Apr 20199:29 amRNSFinal Terms
25th Mar 20195:38 pmRNSFinal Terms
22nd Mar 20193:50 pmRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
15th Mar 20197:00 amRNSFinal Terms
7th Mar 201910:24 amRNSStabilisation Notice
6th Mar 20195:34 pmRNSIssue of Debt
6th Mar 20199:01 amRNSStabilisation Notice
5th Mar 20195:42 pmRNSProspectus Supplement
21st Feb 20195:13 pmRNSAnnual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.